Scholarlink

Objective <p>The clinical impact of underweight on outcomes in patients undergoing surgical aortic valve replacement (SAVR) remains unclear. This study aimed to investigate the prognostic significance of underweight status in patients undergoing SAVR and to identify key determinants of adverse outcomes within this population.</p> Methods <p>805 patients underwent SAVR between January 2016 and December 2021 at eight Japanese centers. After excluding 31 patients with missing laboratory data, a total of 774 patients were included. Patients were categorized into underweight group (Body mass index [BMI] &lt; 18.5&#xa0;kg/m², 79 patients), normal-weight group (BMI 18.5–25&#xa0;kg/m², 464 patients), and overweight group (BMI　≥25&#xa0;kg/m², 231 patients). The primary endpoint was all-cause mortality.</p> Results <p>The median age was 76 years (interquartile range [IQR]: 71–79), and the median BMI was 23.3&#xa0;kg/m² (IQR: 20.9–25.8). Underweight patients had the highest 5-year mortality, followed by normal-weight and overweight patients (23.5%, 11.9%, and 7.4%; <i>p</i> = 0.001). In multivariable analysis, BMI was an independent predictor of mortality (1.0&#xa0;kg/m² increase, adjusted hazard ratio: 0.92; 95% confidence interval: 0.86 to 0.99; <i>p</i> = 0.020). Among underweight patients, serum albumin was independently associated with all-cause mortality (<i>p</i> = 0.002). Underweight patients were stratified by median albumin into low (&lt; 4.0&#xa0;g/dL, <i>n</i> = 43) and normal (≥ 4.0&#xa0;g/dL, <i>n</i> = 36) groups, and 5-year mortality was higher in the low albumin group (34.1% vs. 12.6%, <i>p</i> = 0.015).</p> Conclusions <p>Low BMI was associated with higher mortality after SAVR, and serum albumin provided additional risk stratification within underweight group.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognostic utility of serum albumin in underweight patients who underwent isolated surgical aortic valve replacement

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月27日

查看全文
  • Takahiro Ohmori,
  • Koichi Maeda,
  • Kyongsun Pak,
  • Akinobu Ohtani,
  • Yusuke Yanagino,
  • Kazuma Handa,
  • Takura Taguchi,
  • Koichi Inoue,
  • Ai Kawamura,
  • Shigeru Miyagawa

摘要

Objective

The clinical impact of underweight on outcomes in patients undergoing surgical aortic valve replacement (SAVR) remains unclear. This study aimed to investigate the prognostic significance of underweight status in patients undergoing SAVR and to identify key determinants of adverse outcomes within this population.

Methods

805 patients underwent SAVR between January 2016 and December 2021 at eight Japanese centers. After excluding 31 patients with missing laboratory data, a total of 774 patients were included. Patients were categorized into underweight group (Body mass index [BMI] < 18.5 kg/m², 79 patients), normal-weight group (BMI 18.5–25 kg/m², 464 patients), and overweight group (BMI　≥25 kg/m², 231 patients). The primary endpoint was all-cause mortality.

Results

The median age was 76 years (interquartile range [IQR]: 71–79), and the median BMI was 23.3 kg/m² (IQR: 20.9–25.8). Underweight patients had the highest 5-year mortality, followed by normal-weight and overweight patients (23.5%, 11.9%, and 7.4%; p = 0.001). In multivariable analysis, BMI was an independent predictor of mortality (1.0 kg/m² increase, adjusted hazard ratio: 0.92; 95% confidence interval: 0.86 to 0.99; p = 0.020). Among underweight patients, serum albumin was independently associated with all-cause mortality (p = 0.002). Underweight patients were stratified by median albumin into low (< 4.0 g/dL, n = 43) and normal (≥ 4.0 g/dL, n = 36) groups, and 5-year mortality was higher in the low albumin group (34.1% vs. 12.6%, p = 0.015).

Conclusions

Low BMI was associated with higher mortality after SAVR, and serum albumin provided additional risk stratification within underweight group.